ASTRAZENECA PHARMA INDIA
Back to Cashflow Statement
|
ASTRAZENECA PHARMA INDIA Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹31 Cr | ₹5.23 Cr | ₹52 Cr | ₹96 Cr | ₹269 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ASTRAZENECA PHARMA INDIA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹31 Cr |
| Mar2024 | ₹5.23 Cr |
| Mar2023 | ₹52 Cr |
| Mar2022 | ₹96 Cr |
| Mar2021 | ₹269 Cr |
How is Net Cash Inflow / Outflow of ASTRAZENECA PHARMA INDIA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹31 Cr | 484.51 | |
| Mar2024 | ₹5.23 Cr | -89.93 | |
| Mar2023 | ₹52 Cr | -45.96 | |
| Mar2022 | ₹96 Cr | -64.26 | |
| Mar2021 | ₹269 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹21,510.6 Cr | 1.2% | 1.9% | 7.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | 1.2% |
1.9% |
7.6% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses